InvestSMART

Clever Culture Systems Limited (ASX: CC5) - Announcements

Current share price for CC5 : $0.019 0.001 (5%)+

ASX company news and announcements for Clever Culture Systems Limited (CC5) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clever Culture Systems Limited (CC5) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clever Culture Systems Limited (CC5), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clever Culture Systems Limited (CC5)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$41 Application for quotation of securities - CC5 7 Nov 2025 6:51PM $0.029 $0.019 fallen by 34.48%
$41 Application for quotation of securities - CC5 6 Nov 2025 11:02AM $0.028 $0.019 fallen by 32.14%
$41 Application for quotation of securities - CC5 31 Oct 2025 5:19PM $0.030 $0.019 fallen by 36.67%
$41 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2025 9:20AM $0.030 $0.019 fallen by 36.67%
$41 Becoming a substantial holder 21 Oct 2025 11:29AM $0.030 $0.019 fallen by 36.67%
$41 Application for quotation of securities - CC5 21 Oct 2025 11:25AM $0.030 $0.019 fallen by 36.67%
$41 Letter to Option Holders 17 Oct 2025 9:32AM $0.030 $0.019 fallen by 36.67%
$41 Notice of Annual General Meeting/Proxy Form 14 Oct 2025 9:44AM $0.033 $0.019 fallen by 42.42%
$41 Change in substantial holding 2 Oct 2025 3:51PM $0.034 $0.019 fallen by 44.12%
$41 Change in substantial holding 2 Oct 2025 8:26AM $0.034 $0.019 fallen by 44.12%
$41 Change in substantial holding 2 Oct 2025 8:26AM $0.034 $0.019 fallen by 44.12%
$41 Change of Director's Interest Notice - B Barnes 2 Oct 2025 8:26AM $0.034 $0.019 fallen by 44.12%
$41 Change of Director's Interest Notice - R Wilson 2 Oct 2025 8:26AM $0.034 $0.019 fallen by 44.12%
$41 Application for quotation of securities - CC5 1 Oct 2025 6:09PM $0.034 $0.019 fallen by 44.12%
$41 Appendix 4G 15 Sep 2025 8:27AM $0.034 $0.019 fallen by 44.12%
$41 Corporate Governance Statement 15 Sep 2025 8:27AM $0.034 $0.019 fallen by 44.12%
$41 Annual Report to shareholders 15 Sep 2025 8:26AM $0.034 $0.019 fallen by 44.12%
$41 Application for quotation of securities - CC5 11 Sep 2025 9:57AM $0.033 $0.019 fallen by 42.42%
$41 Top-Tier Pharma to Showcase APAS Results 8 Sep 2025 10:05AM $0.030 $0.019 fallen by 36.67%
$41 Application for quotation of securities - CC5 4 Sep 2025 9:44AM $0.032 $0.019 fallen by 40.63%
$41 Notification of cessation of securities - CC5 1 Sep 2025 9:26AM $0.032 $0.019 fallen by 40.63%
$41 Annual Financial Report 28 Aug 2025 9:55AM $0.034 $0.019 fallen by 44.12%
$41 Appendix 4E 28 Aug 2025 9:45AM $0.034 $0.019 fallen by 44.12%
$41 APAS Contact Plate Application Product Launch 27 Aug 2025 8:16AM $0.035 $0.019 fallen by 45.71%
$41 Application for quotation of securities - CC5 18 Aug 2025 9:12AM $0.035 $0.019 fallen by 45.71%

51 - 75 of 103 results

Page 3 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.